CClinicalTrials.gg
CompletedNCT05533723Updated Sep 9, 2022

Comparison Between Endoscopic Epidural Neuroplasty and Percutaneous Epidural Neuroplasty in Low Back and Radicular Pain

An observational study in Low Back Pain and Radiculopathy, sponsored by Ajou University School of Medicine. Completed at 1 site in Korea, Republic of. Per ClinicalTrials.gov, last updated 2022-09-09.

Sponsored by Ajou University School of Medicine · Observational

Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
107
01

Study summary

PEN(percutaneous epidural neuroplasty) can be performed percutaneously, may be manipulated to mechanically break up adhesions by catheter, while various agents, such as anesthetics, corticosteroids, hyaluronidase, and hypertonic saline are injected. In endoscopic epidural neuroplasty (EEN), a flexible catheter is inserted into the sacral hiatus to precisely place the injection in the epidural space and onto the nerve root. Both EEN and PEN can eliminate the deleterious effects of scar formation, which can physically prevent the direct application of drugs to the nerves, and may provide pain relief in patients who have not responded to epidural blocks, physical therapy, or medication. In this study, visual analog scale (VAS) and Oswestry disability index (ODI) of patients with low back and radicular pain were compared in patients who had received EEN or PEN at 1 day, 1 month, and 6 months after EEN or PEN.

Read the detailed description

Low back pain and lumbar radicular pain commonly occur in degenerative spondy-losis. Low back and radicular pain have many underlying causes, one of which is scar-ring in the epidural space, which can cause pain for many reasons. The nerves may be trapped by scars, while the congestive veins in the epidural space can become enlarged and exert pressure upon the nerves.

Percutaneous epidural neuroplasty (PEN) with a wire type catheter, first reported by Dr. Racz, has been widely practiced since 1989, and reduces pain by epidural adhesiolysis, epidural fibrosis and inflammation near the neural tissue.

The PEN procedure is used to dissolve some scar tissue around the entrapped nerves in the epidural space of the spine. PEN can be performed percutaneously, using a Racz catheter. The catheter may be manipulated to mechanically break up adhesions, while various agents, such as anesthetics, corticosteroids, hyaluronidase, and hypertonic saline are injected. In endoscopic epidural neuroplasty (EEN), a flexible catheter is inserted into the sacral hiatus to precisely place the injection in the epidural space and onto the nerve root. Both EEN and PEN can eliminate the deleterious effects of scar formation, which can physically prevent the direct application of drugs to the nerves, and may pro-vide pain relief in patients who have not responded to epidural blocks, physical therapy, or medication.

In this study, visual analog scale (VAS) and Oswestry disability index (ODI) of pa-tients with low back and radicular pain were compared in patients who had received EEN or PEN at 1 day, 1 month, and 6 months after EEN or PEN.

02

Conditions studied

  • Low Back Pain
  • Radiculopathy
03

In context

Radiculopathy

488 studies on the registry are indexed under Radiculopathy; 141 are open to participants now.

This study's enrollment of 107 is above the median of 93 across 98 observational studies indexed under Radiculopathy.

Browse Radiculopathy studies →

Lead sponsor

Ajou University School of Medicine is the lead sponsor of 171 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sampling method
Non-probability sample

Study population

Patients who visited Ajou University Hospital pain clinic with back and radiating pain from 2016 to 2020

Inclusion criteria

  1. age over 20 years
  2. low back or radicular pain in the low extremities
  3. persistent low back or radicular pain

Exclusion criteria

Exclusion Criteria:

  1. systemic infection
  2. skin infection at the injection site
  3. uncontrolled diabetes mellitus
  4. coagulation abnormalities
  5. history of allergic reactions to local anesthetics or contrast agents
05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
107 participants (actual)
Patient registry
No

Groups and cohorts

  • Percutaneous epidural neuroplasty (PEN) group

    Patients over 20 years of age with radiating pain in the lower back and legs who received PEN in patients who did not respond to medication and epidural nerve block treatment.

    Procedure: Percutaneous epidural neuroplasty (PEN)

  • Endoscopic epidural neuroplasty (EEN) group

    Patients over 20 years of age with radiating pain in the lower back and legs who received EEN in patients who did not respond to medication and epidural nerve block treatment.

    Procedure: Endoscopic epidural neuroplasty

Interventions

  • ProcedureEndoscopic epidural neuroplasty

    EEN catheter, iDolphine S2 (Meta Biomed Co., Ltd, Osong, Korea) was placed in the epidural space through sacral hiatus. EEN was done on the target segments. During EEN, normal saline was infused into epidural space under epiduroscopic vision. Dexamethasone (5 mg), 0.3% mepivacaine 10 mL, and hyaluronidase (3000 IU) were injected through catheter at the target segments. Holmium-Yag laser was used to cut epidural fibrous bands and for coagulation of epidural bleeding.

    Also known as: Percutaneous epidural neuroplasty (PEN)

  • ProcedurePercutaneous epidural neuroplasty (PEN)

    PEN catheter, EDEN-CC (JMT, Yangju, Korea) was placed in the epidural space and neural foramen . PEN was done on the target segments. Dexamethasone (5 mg), 0.3% mepivacaine 10 ml, and hyaluronidase (3000 IU) were injected through the PEN catheter.

06

What researchers measure

Primary outcomes

  1. visual analog scale

    11 points pain scale score from 0 to 10

    Time frame: 6 months after EEN or PEN

  2. Oswestry disability index

    disability index from 0 to 100%

    Time frame: 6 months after EEN or PEN

Secondary outcomes

  1. weight

    kg

    Time frame: before EEN or PEN

  2. height

    m

    Time frame: before EEN or PEN

07

Study locations

1 site
  • Ajou University Hospital
    Suwon, Gyunggi 16499, Korea, Republic of
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 9, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05533723
Lead sponsor
Ajou University School of Medicine
Responsible party
Jong Bum Choi (professor, Ajou University School of Medicine) — Principal investigator
First posted
Sep 9, 2022
Start date
Oct 10, 2018
Primary completion
Aug 24, 2022
Completion
Aug 24, 2022
Last update
Sep 9, 2022

Study contacts

Jong Bum Choi
study director · Ajou University School of Medicine

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion